awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q50662692-0AA4286E-AB6F-4ED3-B5E5-1F51FD2C5692
Q50662692-0AA4286E-AB6F-4ED3-B5E5-1F51FD2C5692
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50662692-0AA4286E-AB6F-4ED3-B5E5-1F51FD2C5692
Therapeutic potential of spleen tyrosine kinase inhibition for treating high-risk precursor B cell acute lymphoblastic leukemia.
P2860
Q50662692-0AA4286E-AB6F-4ED3-B5E5-1F51FD2C5692
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50662692-0AA4286E-AB6F-4ED3-B5E5-1F51FD2C5692
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f88c8478b13eded2e11c935695978aaab6161dba
P2860
Discovery of N-(2-chloro-6-methyl- phenyl)-2-(6-(4-(2-hydroxyethyl)- piperazin-1-yl)-2-methylpyrimidin-4- ylamino)thiazole-5-carboxamide (BMS-354825), a dual Src/Abl kinase inhibitor with potent antitumor activity in preclinical assays.